EUVIMEDEUVIMED entdecken
Übersichtsarbeit

In Search for Inhibitors of Human Aldo-Keto Reductase 1B10 (AKR1B10) as Novel Agents to Fight Cancer and Chemoresistance: Current State-of-the-Art and Prospects

Rosanna Maccari iD, Rosaria Ottanà

Journal of Medicinal Chemistry · 23.01.2025 · 68 (2) · 860-885

DOI: 10.1021/acs.jmedchem.4c01116 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.01.2025. Verfasst von Rosanna Maccari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno D'Alcontres, 31-98166 Messina, …. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Antineoplastic Agents, Neoplasms, Enzyme Inhibitors. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 125 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aldo-keto reductase 1B10 (AKR1B10) is a human enzyme that catalyzes the NADPH-dependent reduction of several different carbonyl compounds to the corresponding alcohols. Under physiological conditions, AKR1B10 is expressed mainly in the gastrointestinal tract, where it can detoxify reactive carbonyl compounds derived from dietary sources and xenobiotics. AKR1B10 is highly expressed in several cancers and precancerous conditions, proving to be crucially implicated in carcinogenesis and to function as a prognostic indicator of tumor development. Moreover, AKR1B10 up-regulation is strictly related to acquired resistance to known anticancer drugs. High levels of this enzyme are also correlated to the pathogenesis of noncancerous diseases, such as skin pathologies and COVID-19 complications. Therefore, in the last two decades, AKR1B10 has attracted interest as a novel target for agents able to fight both cancer and chemoresistance, and here, it is explored from a medicinal chemistry perspective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmAntineoplastic AgentsNeoplasmsEnzyme InhibitorsAldo-Keto Reductase Family 1 member B10HumansAldo-Keto Reductases

Substanzen

AKR1B10 protein, humanAntineoplastic AgentsEnzyme InhibitorsAldo-Keto Reductase Family 1 member B10Aldo-Keto Reductases

Autor:innen und Institutionen

  • Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno D'Alcontres, 31-98166 Messina, Italy.

ORCID-Profile: Rosanna Maccari

Zitieren

APA

Maccari, R., & Ottanà, R. (2025). In Search for Inhibitors of Human Aldo-Keto Reductase 1B10 (AKR1B10) as Novel Agents to Fight Cancer and Chemoresistance: Current State-of-the-Art and Prospects. Journal of Medicinal Chemistry, 68(2), 860-885. https://doi.org/10.1021/acs.jmedchem.4c01116

Vancouver

Maccari R, Ottanà R. In Search for Inhibitors of Human Aldo-Keto Reductase 1B10 (AKR1B10) as Novel Agents to Fight Cancer and Chemoresistance: Current State-of-the-Art and Prospects. Journal of Medicinal Chemistry. 2025;68(2):860-885. doi:10.1021/acs.jmedchem.4c01116

BibTeX
@article{Maccari2025,
  author = {Maccari, Rosanna and Ottanà, Rosaria},
  title = {In Search for Inhibitors of Human Aldo-Keto Reductase 1B10 (AKR1B10) as Novel Agents to Fight Cancer and Chemoresistance: Current State-of-the-Art and Prospects},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {2},
  pages = {860--885},
  doi = {10.1021/acs.jmedchem.4c01116}
}
Kostenlos starten →